Gedea Biotech Ab
Clinical trials sponsored by Gedea Biotech Ab, explained in plain language.
-
New yeast infection treatment shows promise in small study
Disease control CompletedThis study tested a new vaginal tablet (pessary) called Gedea in 26 adult women with yeast infections. The treatment was used daily for 6 days. The main goal was to see if it could clear signs and symptoms like itching, burning, and redness within 7 to 14 days. The study also che…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated May 01, 2026 21:27 UTC
-
New Non-Antibiotic tablet shows promise for recurring vaginal infections
Disease control CompletedThis study tested the safety of a vaginal tablet called pHyph in 32 adult women with bacterial vaginosis (BV). pHyph uses a natural substance to restore the vagina's acidity, helping good bacteria thrive and reducing bad bacteria. Participants used the tablet daily for 12 days, a…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC